MedPath

Study on supplementing children with abnormal body movements with a oral Vitami

Not Applicable
Completed
Conditions
Health Condition 1: null- Children with epilepsy on anti-epileptic drug therapy
Registration Number
CTRI/2017/08/009234
Lead Sponsor
ady Hardinge Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

1. Children of 5 - 10 years

2. Started on anti epileptic drug therapy within the past 2 weeks of presenting to the OPD / Epilepsy clinic or fresh cases of seizures started on anti epileptic drugs in the hospital

3. Started on or receiving either or combined phenytoin, valproate, carbamazepine, phenobarbitone or other newer anti-epileptic drugs

4. Normal nutritional status - BMI within +/- 2 Z scores of WHO standards

Exclusion Criteria

1. Children on calcium or vitamin D supplements currently or receiving it in the last 6 months

2. Clinical or biochemical evidence of rickets

3. Any chronic illness that can influence vitamin D metabolism ( chronic liver disease, chronic kidney disease and malabsorption states)

4. Non ambulatory patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of supplementation with 60,000 IU of vitamin D per month for a period of 6 months on the serum levels of 25 hydroxy Vitamin D {25 (OH) D} in pre-pubertal children freshly started on anti-epileptic drug medicationsTimepoint: To assess the effect of supplementation with 60,000 IU of vitamin D per month for a period of 6 months on the serum levels of 25 hydroxy Vitamin D {25 (OH) D} in pre-pubertal children freshly started on anti-epileptic drug medications
Secondary Outcome Measures
NameTimeMethod
To compare the indicators of bone turn over - serum calcium, serum Alkaline phosphatase, serum parathyroid hormone and serum inorganic phosphate in supplemented children as compared to those not similarly supplementedTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath